Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With de Novo Coronary Artery Lesions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00300131
What this trial is testing

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Abbott Medical Devices 30
Testing effectiveness (Phase 2)Study completedNCT00233714
What this trial is testing

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 56
Not applicableStudy completedNCT00792753
What this trial is testing

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 360
Post-approval studies (Phase 4)Study completedNCT04483791
What this trial is testing

DynamX Bioadaptor Hong Kong Registry

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 50
Large-scale testing (Phase 3)Study completedNCT00381420
What this trial is testing

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 100
Large-scale testing (Phase 3)UnknownNCT00637104
What this trial is testing

European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent

Who this might be right for
Coronary Artery DiseaseAngioplasty, Transluminal, Percutaneous CoronaryStents
International Biomedical Systems S.p.A. 160
Not applicableLooking for participantsNCT07463664
What this trial is testing

Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions

Who this might be right for
Chronic Total Occlusions of Coronary ArteriesChronic Total Occlusion (CTO)Coronary Artery Disease (CAD)
The First Affiliated Hospital of Zhengzhou University 200
Large-scale testing (Phase 3)Study completedNCT00180310
What this trial is testing

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Abbott Medical Devices 300
Testing effectiveness (Phase 2)Study completedNCT00233805
What this trial is testing

The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 220
Not applicableNot Yet RecruitingNCT07582250
What this trial is testing

A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Efficacy of Biolimus Drug-Coated Balloon (DCB) Versus Drug-Eluting Stent (DES) in the Treatment of De Novo Coronary Artery Lesions

Who this might be right for
Patients With de Novo Coronary Artery Lesions
JW Medical Systems Ltd 1,548
Large-scale testing (Phase 3)Study completedNCT00322569
What this trial is testing

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Who this might be right for
Coronary Disease
Cordis US Corp. 246
Large-scale testing (Phase 3)Ended earlyNCT00322543
What this trial is testing

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

Who this might be right for
Coronary Disease
Conor Medsystems 3
Large-scale testing (Phase 3)Study completedNCT00371709
What this trial is testing

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Boston Scientific Corporation 871
Not applicableLooking for participantsNCT05438121
What this trial is testing

STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)

Who this might be right for
Coronary Artery DiseaseAtherosclerotic PlaqueDe Novo Stenosis
Korea University Ansan Hospital 65
Not applicableUnknownNCT02698852
What this trial is testing

Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Who this might be right for
Coronary Artery Disease
Sino Medical Sciences Technology Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT00180453
What this trial is testing

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Who this might be right for
Coronary Artery DiseaseEverolimusVascular Disease+2 more
Abbott Medical Devices 60
Not applicableStudy completedNCT02057978
What this trial is testing

EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.

Who this might be right for
Coronary Artery DiseaseMyocardial IschemiaCoronary Disease+5 more
JW Medical Systems Ltd 419
Post-approval studies (Phase 4)UnknownNCT00825773
What this trial is testing

Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions

Who this might be right for
IschemiaCardiac DeathMyocardial Infarction
JW Medical Systems Ltd 1,944
Not applicableEnded earlyNCT04375085
What this trial is testing

DESyne X2 Post Market Follow-up Study

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 49
Not applicableStudy completedNCT02716220
What this trial is testing

Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)

Who this might be right for
Coronary Artery DiseaseCoronary Artery Stenosis
Biotronik AG 61
Next Page